Evidence map›Paper›PMID 33924830›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Proteomic Charting of Imipenem Adaptive Responses in a Highly Carbapenem Resistant Clinical

Suruchi Nepal, Sandra Maaß, Stefano Grasso, Francis M Cavallo, Jürgen Bartel, Dörte Becher, Erik Bathoorn, Jan Maarten van Dijl

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 64% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Suruchi NepalUniversity Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, University of Groningen, Hanzeplein 1, P.O. Box 30001, 9700 RB Groningen, The Netherlands.ORCID 0000-0001-7822-6921
Sandra MaaßInstitute for Microbiology, University of Greifswald, Felix-Hausdorff-Str. 8, 17489 Greifswald, Germany.ORCID 0000-0002-6573-1088
Stefano GrassoUniversity Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, University of Groningen, Hanzeplein 1, P.O. Box 30001, 9700 RB Groningen, The Netherlands.ORCID 0000-0002-6958-9912
Francis M CavalloUniversity Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, University of Groningen, Hanzeplein 1, P.O. Box 30001, 9700 RB Groningen, The Netherlands.ORCID 0000-0003-3270-3205
Jürgen BartelInstitute for Microbiology, University of Greifswald, Felix-Hausdorff-Str. 8, 17489 Greifswald, Germany.
Dörte BecherInstitute for Microbiology, University of Greifswald, Felix-Hausdorff-Str. 8, 17489 Greifswald, Germany.ORCID 0000-0002-9630-5735
Erik BathoornUniversity Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, University of Groningen, Hanzeplein 1, P.O. Box 30001, 9700 RB Groningen, The Netherlands.
Jan Maarten van DijlUniversity Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, University of Groningen, Hanzeplein 1, P.O. Box 30001, 9700 RB Groningen, The Netherlands.ORCID 0000-0002-5688-8438
University Medical Center Groningen · NLUniversität Greifswald · DE

Funding

Deutsche Forschungsgemeinschaft SFB/TRR 34H2020 Marie Skłodowska-Curie Actions 642836H2020 Marie Skłodowska-Curie Actions 713482
6 · The paper itself

Abstract

Gram-negative bacteria belonging to the

Indexed as

carbapenemEnterobacterimipenemmulti-omicsresistanceSILAC

Identifiers

PMID33924830
PMCPMC8145422
OpenAlexW3158698961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.